Thomas A. Albright MBA

Dr. Albright was formerly Chairman and CEO of Andrew Technologies LLC from 2011 to 2017. In the past, Mr. Albright was President of the topical aesthetic division at Syneron Medical Ltd. and before that Head of North American marketing at Nobel Biocare. From 2000 to 2008, Mr. Albright was VP of BOTOX Global Strategic Marketing at Allergan, where he led the U.S. launch of BOTOX Cosmetic and the commercial development of Latisse. He started his medical industry experience in 1983 at Parke-Davis division of Warner-Lambert, where he was a Director of Marketing on the Lipitor launch team. Mr. Albright was also a Board Director of Bonti Inc. prior to its acquisition by Allergan. Mr. Albright has a BS in biology from The Citadel and an MBA in marketing from Mercer University.